交易 Vir Biotechnology VIR

出售
 購買

VirBiotechnology實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

最新新聞

Frances Wang 2025 Mar 30, 16:00

哈雷戴維森第四季度銷售暴跌：哈雷戴維森的營收下降60%

So Ze Dong 2025 Mar 25, 16:00

S&P500指數三連漲！GameStop宣布投資比特幣股價狂飆

Christine Voong 2025 Mar 21, 07:30

黃金價格走勢受美元走勢影響回落，仍穩守 3,000 美元關口

Christine Voong 2025 Mar 21, 04:40

美元指數走強至 103.81 點，美聯儲維持利率不變，市場關注貿易關稅與美元匯率走勢

Christine Voong 2025 Mar 20, 08:20

黃金價格走勢創歷史新高！現貨金觸及 3,057 美元，美聯儲降息預期與美元走勢疲弱支撐漲勢

Christine Voong 2025 Mar 20, 07:25

比特幣價格走勢上揚！美聯儲維持降息預測，加密貨幣市場風險偏好回暖

Christine Voong 2025 Mar 19, 08:00

國際原油價格走勢承壓：美國原油庫存激增，美俄停火協議影響供應預期

Christine Voong 2025 Mar 19, 07:25

國際黃金價格創歷史新高！避險需求推升，美聯儲決策影響黃金價格走勢

聯絡方式

點差

0.05

點差(%)

0.7764 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

918857600

流通股份

137143008

收益日期（下一個）

0000-00-00

現金殖利率 

除息日

遠期年股息率

0

遠期年現金殖利率

0

每股盈餘

-3.7

了解有關此金融工具的詳細資訊

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具
Trustpilot